BACKGROUND AND PURPOSE: The Framingham Heart Study group cardiovascular disease risk profile (FCRP) score was used to assess the relationship between baseline cardiovascular risk and subsequent changes in resting state cerebral blood flow (CBF) in cognitively normal older participants from the Baltimore Longitudinal Study of Aging. METHODS: Ninty-seven cognitively normal participants underwent annual resting-state positron emission tomography scans at baseline and over a period of up to 8 years (mean interval, 7.4 years). Images quantifying voxel-wise longitudinal rates of CBF change were calculated and used to examine the relationship between baseline FCRP score and changes over time in regional CBF. Individual components of the FCRP score (age, cholesterol, blood pressure, smoking status, and type 2 diabetes) were also correlated with changes in regional CBF to examine the independent contributions of each component to the overall pattern of change. RESULTS: Higher baseline FCRP scores were associated with accelerated longitudinal decline in CBF in orbitofrontal, medial frontal/anterior cingulate, insular, precuneus, and brain stem regions. Of the components that comprise the FCRP score, higher diastolic blood pressure and diabetes were associated independently with greater decline in the medial frontal/anterior cingulate and insular regions, respectively. CONCLUSIONS: Baseline cardiovascular risk factors are associated with greater rates of decline in resting state regional brain function. The regions showing accelerated decline participate in higher-order cognitive processes and are also vulnerable to age-related neuropathology. These results, in conjunction with other studies, encourage early treatment of cardiovascular risk factors in older individuals.
BACKGROUND AND PURPOSE: The Framingham Heart Study group cardiovascular disease risk profile (FCRP) score was used to assess the relationship between baseline cardiovascular risk and subsequent changes in resting state cerebral blood flow (CBF) in cognitively normal older participants from the Baltimore Longitudinal Study of Aging. METHODS: Ninty-seven cognitively normal participants underwent annual resting-state positron emission tomography scans at baseline and over a period of up to 8 years (mean interval, 7.4 years). Images quantifying voxel-wise longitudinal rates of CBF change were calculated and used to examine the relationship between baseline FCRP score and changes over time in regional CBF. Individual components of the FCRP score (age, cholesterol, blood pressure, smoking status, and type 2 diabetes) were also correlated with changes in regional CBF to examine the independent contributions of each component to the overall pattern of change. RESULTS: Higher baseline FCRP scores were associated with accelerated longitudinal decline in CBF in orbitofrontal, medial frontal/anterior cingulate, insular, precuneus, and brain stem regions. Of the components that comprise the FCRP score, higher diastolic blood pressure and diabetes were associated independently with greater decline in the medial frontal/anterior cingulate and insular regions, respectively. CONCLUSIONS: Baseline cardiovascular risk factors are associated with greater rates of decline in resting state regional brain function. The regions showing accelerated decline participate in higher-order cognitive processes and are also vulnerable to age-related neuropathology. These results, in conjunction with other studies, encourage early treatment of cardiovascular risk factors in older individuals.
Authors: S C Burgener; L Buettner; K Coen Buckwalter; E Beattie; A L Bossen; D M Fick; S Fitzsimmons; A Kolanowski; N E Richeson; K Rose; A Schreiner; J K Pringle Specht; I Testad; F Yu; S McKenzie Journal: J Nutr Health Aging Date: 2008-01 Impact factor: 4.075
Authors: Audrey M Tiehuis; Yolanda van der Graaf; Frank L Visseren; Koen L Vincken; Geert Jan Biessels; Auke P A Appelman; L Jaap Kappelle; Willem P T M Mali Journal: Stroke Date: 2008-03-27 Impact factor: 7.914
Authors: Weiying Dai; Oscar L Lopez; Owen T Carmichael; James T Becker; Lewis H Kuller; H Michael Gach Journal: Stroke Date: 2008-01-03 Impact factor: 7.914
Authors: Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: J Richard Jennings; Alicia F Heim; Dora Chieh-Hsin Kuan; Peter J Gianaros; Matthew F Muldoon; Stephen B Manuck Journal: Stroke Date: 2013-07-23 Impact factor: 7.914
Authors: Lindsay R Clark; Megan Zuelsdorff; Derek Norton; Sterling C Johnson; Mary F Wyman; Laura M Hancock; Cynthia M Carlsson; Sanjay Asthana; Susan Flowers-Benton; Carey E Gleason; Heather M Johnson Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Yi-Fang Chuang; Dana Eldreth; Kirk I Erickson; Vijay Varma; Gregory Harris; Linda P Fried; George W Rebok; Elizabeth K Tanner; Michelle C Carlson Journal: Neurobiol Aging Date: 2013-12-18 Impact factor: 4.673
Authors: Thaddeus J Haight; R Nick Bryan; Guray Erus; Christos Davatzikos; David R Jacobs; Mark D'Esposito; Cora E Lewis; Lenore J Launer Journal: Neuroimage Date: 2015-04-24 Impact factor: 7.400